Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus.
The G-protein coupled estrogen receptor 30 (GPR30) is a seven-transmembrane domain receptor that mediates rapid estrogen responses in a wide variety of cell types. This receptor is highly expressed in the cardiovascular system, and exerts vasodilatory effects. The objective of the present study was...
Guardado en:
Autores principales: | Zi-lin Li, Jin-cheng Liu, Shui-bing Liu, Xiao-qiang Li, Ding-hua Yi, Ming-gao Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1adcf93a1c1b4fc0b144602fda25da28 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chronic activation of the G protein-coupled receptor 30 with agonist G-1 attenuates heart failure.
por: Shoulei Kang, et al.
Publicado: (2012) -
Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes
por: Guoxia Ji, et al.
Publicado: (2021) -
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
por: Matthias Apweiler, et al.
Publicado: (2021) -
The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo
por: Yi Huan, et al.
Publicado: (2017) -
Evaluation of the hepatotoxicity of the novel GPR40 (FFAR1) agonist CPL207280 in the rat and monkey.
por: Katarzyna Bazydlo-Guzenda, et al.
Publicado: (2021)